SRTA
Strata Critical Medical, Inc.
NASDAQ · Industrials · Airlines, Airports & Air Services · US
$4.75
−0.21%Year over year
Reported trailing growth
- Revenue
- +0.6%
- EBITDA
- +27.2%
- EBIT
- +16.5%
- EPS
- +316.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +24.4%
- EBITDA
- +499.0%
- EPS
- -88.0%
Three-year CAGR
- Revenue
- +10.5%
- EBITDA
- +73.6%
- EBIT
- +34.1%
- Net income
- +251.4%
- EPS
- +242.9%
- Free cash flow
- -68.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026